How big is the Global Immunomodulators Market?

The Global Immunomodulators Market size is expected to reach USD 230.12 billion in 2024 and grow at a CAGR of 6.5% to reach USD 315.11 billion by 2029. Read More

What is the current Global Immunomodulators Market size?

In 2024, the Global Immunomodulators Market size is expected to reach USD 230.12 billion. Read More

Who are the key players in Global Immunomodulators Market?

Pfizer Inc, Astellas Pharma Inc., F. Hoffmann-La Roche Ltd.,, Biogen and Bristol Myers Squibb are the major companies operating in the Global Immunomodulators Market. Read More

Which is the fastest growing region in Global Immunomodulators Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Immunomodulators Market?

In 2024, the North America accounts for the largest market share in Global Immunomodulators Market. Read More

What years does this Global Immunomodulators Market cover, and what was the market size in 2023?

In 2023, the Global Immunomodulators Market size was estimated at USD 215.16 billion. The report covers the Global Immunomodulators Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Immunomodulators Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Immunomodulators Market Share

Statistics for the 2023 & 2024 Global Immunomodulators market share, created by Mordor Intelligence™ Industry Reports. Global Immunomodulators share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Immunomodulators Industry

This industry is predicted to witness intense competition over the forecast period owing to the increasing adoption of disruptive strategies amongst market players to sustain themselves in the competition. The strategies include distribution channel enhancement, extensive product development activities, mergers & acquisitions, and collaborative agreements for drug development. Some of the key market players operating in the arena of the immunomodulator industry are F. Hoffmann-La Roche Ltd., Amgen, Inc.; Biogen, Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Merck % Co Inc.., Eli Lilly and Company, Pfizer Inc., and Acrotech Biopharma, LLC Inc among others.